In murine breast cancer models, 7-isopentenyloxycoumarin has been found to exhibit potent antiangiogenic activity by modulating CCL2 chemokine signaling, leading to decreased tumor vascularization and growth [119]. The gene discussed is CCL2; the disease is neoplasm.